Next Article in Journal
Dynamic Stability of Volatile Organic Compounds in Respiratory Air in Schizophrenic Patients and Its Potential Predicting Efficacy of TAAR Agonists
Next Article in Special Issue
The Antimicrobial and Mosquitocidal Activity of Green Magnesium Oxide Nanoparticles Synthesized by an Aqueous Peel Extract of Punica granatum
Previous Article in Journal
Ligand-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations of New β-Estrogen Receptor Activators with Potential for Pharmacological Obesity Treatment
Previous Article in Special Issue
One-Step Construction of Tryptophan-Derived Small Molecule Hydrogels for Antibacterial Materials
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 11
10.3390/molecules28114390
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Antibacterial and Cytocompatible pH-Responsive Peptide Hydrogel

by
Dona Imanga Upamadi Edirisinghe
1,
Areetha D’Souza
1,
Maryam Ramezani
2,
Robert J. Carroll
3,
Quenten Chicón
1,
Cheyene L. Muenzel
1,
Jonathan Soule
1,
Mary Beth Browning Monroe
2,
Alison E. Patteson
3 and
Olga V. Makhlynets
1,*
1
Department of Chemistry, Syracuse University, 111 College Place, Syracuse, NY 13244, USA
2
Biomedical and Chemical Engineering, Syracuse University, Bowne Hall, Syracuse, NY 13210, USA
3
Department of Physics, Syracuse University, Syracuse, NY 13210, USA
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(11), 4390; https://doi.org/10.3390/molecules28114390
Submission received: 2 March 2023 / Revised: 2 May 2023 / Accepted: 3 May 2023 / Published: 27 May 2023
(This article belongs to the Special Issue Recent Advances in Antimicrobial Materials)
Browse Figures
Versions Notes

Abstract

:
A short peptide, FHHF-11, was designed to change stiffness as a function of pH due to changing degree of protonation of histidines. As pH changes in the physiologically relevant range, G′ was measured at 0 Pa (pH 6) and 50,000 Pa (pH 8). This peptide-based hydrogel is antimicrobial and cytocompatible with skin cells (fibroblasts). It was demonstrated that the incorporation of unnatural AzAla tryptophan analog residue improves the antimicrobial properties of the hydrogel. The material developed can have a practical application and be a paradigm shift in the approach to wound treatment, and it will improve healing outcomes for millions of patients each year.

1. Introduction

The pH of wounds changes during wound healing, going from pH ~5.5 when first made to pH ~8 when almost resolved [1]. This property of wounds motivates us to design a hydrogel material that adapts its stiffness to different pH values and could be used to adapt to different healing stages, thus facilitating the wound-healing process by releasing encapsulated fibroblasts at a reduced pH. The delivery of fibroblasts and keratinocytes has been used as a cell-based therapy for wound healing [2]. Other desirable characteristics of such materials would be self-healing ability and antimicrobial properties. Adaptable gels are shear-thin and flow under applied strain but recover their gel properties once the stress has been removed [3,4,5]. Self-healing hydrogels do not leak to neighboring tissues and can be delivered by injection, and they could re-anneal in the wound bed or in the destination site, providing a convenient form of application [6,7]. Antimicrobial hydrogels are especially popular as wound dressings because they provide both a moist environment and antimicrobial protection, resulting in improved healing outcomes [8,9,10,11]. Finally, the hydrogel material should be cytocompatible with the skin cells; therefore, we chose to use peptides for the hydrogel formation because they are generally cytocompatible [12,13,14,15,16]. The small size of the peptides gives them an advantage over natural materials [17] (such as alginate [18]) as they can be easily modified (e.g., via the introduction of non-canonical amino acids, RGD motif, etc.) [12,13,14,15,19,20,21].
Based on the above requirements, a hydrogel material suitable for wound healing applications was designed. The advantage of using peptide-based materials when compared to polymeric materials (natural or synthetic) is their ease of synthesis and incorporation of modifications (such as non-natural amino acids and RGD motif) and their cytocompatibility [12,13,14,15,19,20,21]. A synergistic combination of multiple properties is important because self-healing is essential for the delivery of the hydrogel via a syringe, and antimicrobial properties and cytocompatibility are critical for practical applications.
To create the hydrogel material, a peptide scaffold was used. Current peptide-based hydrogels lack some characteristics, as shown in Table S1. In contrast, our material combines all the characteristics necessary for an injectable wound dressing: self-healing, antimicrobial properties, cytocompatibility, and pH sensitivity. The peptide sequence was designed based on our previous results and the literature review. We had already successfully shown that a hydrogel material with Cu(II) can change the stiffness in response to copper reduction [22], and the peptide in that work served as the starting point of the design for this work.
In this work, the first goal was achieved—the design of an antimicrobial, injectable, cytocompatible peptide hydrogel that is sensitive to changes in pH. The next step would be cell encapsulation and protection of fibroblasts during injection. Additionally, this work showed that having AzAla residues in the peptide sequence improves the antimicrobial properties of hydrogels. What makes our hydrogel system unique is a synergistic combination of stimuli responsiveness and antimicrobial peptides in a self-healing hydrogel, properties that are useful for wound healing applications [8,12,23,24,25,26,27,28,29]. Wounds from pressure ulcers [30], diabetic ulcers [31], surgery, or burns are serious global health issues that affect millions of patients worldwide [32], and our hydrogel material is suitable for the healing of wounds.

2. Results

Peptide design: Based on our previous work and the data from the literature, the core of the peptide was designed to include phenylalanines and histidines. We also included two arginine residues to increase the antimicrobial properties of the peptide (Figure 1) [33,34,35,36]. The resulting peptide was shown to assemble into a hydrogel at pH 8 but not pH 6 (Figure 1). The presence of two arginine residues in the sequence should increase the bactericidal activity due to the cationic charge, which we demonstrate through the antimicrobial studies described in this work. Presumably, hydrogel dissipates at a lower pH due to the protonation of histidines and the increase in electrostatic repulsion. Therefore, the presence of histidines drives pH sensitivity as histidines have a pKa value of 6, below which it gets protonated, making the peptide backbone positively charged. Phenylalanine side chains impart hydrophobicity to the peptide and support the self-assembly through π–π stacking interactions leading to the formation of the hydrogel [37].
The sequence of the FHHF-11 peptide (Figure 1) was further modified to evaluate Arg to Lys substitution and the relative position of histidine. Due to a ~2 unit drop in the side chain pKa of free amino acid, we envisioned that replacing Arg in the FHHF-11 sequence with Lys would result in peptide gelation at a lower and more physiological pH value. Changing just one Lys with Arg in MAX1 produced a more rigid gel at pH 8 [38]. We prepared the corresponding peptide but did not observe significantly different behaviors in gelation or pH sensitivity (Table 1, Figure S1). Removing terminal Phe residue or placing Phe between His resulted in no observed formation of hydrogel (Table S2). We conclude that peptides assemble into β-sheet fibers based on CD and TEM spectra and our previous results with Phe-containing sequences (Figure S2) [22].
Antimicrobial properties: In addition to having a peptide that assembles into a good hydrogel, we would like to create antimicrobial material. Generally, antimicrobial peptides are short, cationic, and amphiphilic molecules that evolved over time to selectively kill bacteria but be cytocompatible toward mammalian cells and show little potential for resistance development [26,39].
We measured the antimicrobial properties of FHHF-11 hydrogel using both Gram-negative (E. coli) and Gram-positive (S. aureus) organisms and showed that hydrogel killed S. aureus organisms and, to a lesser extent, E. coli in contact with the material for 13 h (Figure 2). However, the effect of antimicrobial properties enhancement by incorporation of AzAla in the sequence was more pronounced in the case of E. coli. The fact that antibiotics are more efficient toward Gram-positive bacteria is well documented [40,41,42]. The contribution of arginines to antimicrobial properties was tested by using the FHHF-K sequence along with FHHF-11 (Figure S3), but unfortunately, we did not see an improvement of K over R in antimicrobial properties of peptide hydrogel. To further improve gelation and antimicrobial properties, we replaced Phe or Arg in the sequence with Trp. Peptides with tryptophan in the sequence have been reported to have better antimicrobial properties and better cytocompatibility [43,44,45]. We investigated the contributions of a cation-π interaction to the antibacterial activity of a newly designed peptide hydrogel. Cation-π interactions are a common feature of many antibacterial peptides, where they assist in the disruption of bacterial membranes. In Table S2, we compare the influence of tryptophan on the gelation properties of FHHF-11. Replacing Phe or Arg with Trp decreased the stiffness of the hydrogel and did not improve the antimicrobial properties of FHHF-11. However, FHHF-11 hydrogel (1 wt%) had improved antimicrobial properties when AzAla amino acid was incorporated (Figure 2), although the effect observed is not very significant. Non-natural amino acid Azulenyl-Alanine (AzAla) was developed as an analog of tryptophan [46]. Substitution of tryptophan by AzAla would allow studying the mechanism of action of AMPs by using unique properties of this amino acid, such as the ability to be excited separately from tryptophan in multi-Trp AMPs and environmental insensitivity. In our previous work, we found that the antimicrobial and bactericidal activity of the original peptide was preserved, while cytocompatibility with human cells and proteolytic stability was improved [47]. In this work, we investigate the effect of Trp → AzAla substitution on the formation of hydrogel and its antimicrobial properties (Table 1).
Cytotocixity: The gels were tested for cytotoxicity against mouse embryonic fibroblasts (3T3, ATCC) since fibroblasts are a major group of cells that are considered to perform an important role in wound repair and healing [48]. The cytotoxicity was evaluated using live/dead assay, and the prepared gel was incubated with cells for 5 h to observe the cell attachment. Having a very low number of dead cells in the presence of the peptide (Figure 3) suggests that the hydrogel has very low toxicity towards mammalian cells. Next, we prepared the RGD derivative of the peptide and measured that it forms a good hydrogel material with higher cell attachment as compared to the parent sequence (Figure S4, Table 1). RGD [49,50,51], an integrin binding sequence present in ECM proteins, is widely utilized to enhance cell adhesion to mammalian cells [20,52,53,54,55,56,57]. The spacer length between RGD and hydrogel is very important for proper cell adhesion [58]. In this work, we showed that introduction of RGD linked with a single C-terminal glycine leads to some stiffness loss, but the peptide still assembles into the hydrogel. The placement of RGD and the linker is critical as it prevents hydrogel formation if it located at the N-terminus (our previous unpublished results). We used 1 wt% peptide to form a gel as this concentration of peptide was used throughout the manuscript; however, we are planning to use a higher concentration in the future to be able to evaluate peptide toxicity more precisely.
Rheology: Frequency sweep and strain sweep experiments were performed at 0.2% strain and 1 Hz frequency, respectively, to ensure that all subsequent rheology experiments were within the linear viscoelastic (LVE) regime (Figure S5). The storage modulus G′ (51.5 ± 0.5 kPa) was found to be greater than the loss modulus G″ (9 ± 1 kPa), which is a known property of a gel (Figure 4a). Hydrogels typically have a G′ that is about an order of magnitude greater than G″ [59]. A mixture of HEPES and MOPS buffers were used to cover a wide range of pH values and eliminate possible buffer effects (Figure 4b). The final G′ value of the hydrogel exhibited a decreasing trend upon decreasing the pH of the gel medium, with the gel failing to form at pH 6 (Table 1). This decrease can be correlated to the protonation of side chains of histidine residues at lower pH. Self-healing is essential for the delivery of the hydrogel via a syringe. Such adaptable gels are shear-thin and flow under applied strain but recover their gel properties once the stress has been removed [3,4,5]. The self-healing properties of the gel were tested by applying a large shear strain amplitude (1000% strain) for a short time before allowing the gel to recover for 1 h (Figure 4c). The gel exhibited 20% recovery from its initial G’ value of 65 kPa. An image of the hydrogel after 15 min self-healing is shown in Figure S6. To test the extent of self-healing, several cycles of repair were monitored at 0.2% strain after applying 1000% strain (1 h recovery) (Figure S7). The hydrogel appears to demonstrate self-healing in the tested range of pH (7–8), the pH range needed for self-healing in wound dressing. Lower pH values are expected to solubilize the gel and release encapsulated fibroblasts. We also evaluated the dissolution of hydrogel upon exposure to a buffer of low pH. In this experiment, we observed that for a hydrogel preformed at pH 8, the hydrogel quickly dissolved in pH 6 buffer but remained a stable hydrogel composite in pH 8 buffer (Figure 5). Finally, to test the hydrogels’ potential use in wound healing experiments, we evaluated the hydrogel stiffness in response to the presence of metal cations (Figure S8). For the cations Ca(II) and Mg(II) [60,61,62] at concentrations present in physiological fluids, we observed no change in the gelation of the material, even at high concentrations (6 mM final metal concentration).

3. Discussion

We designed a peptide called FHHF-11 that assembles into a pH-sensitive, antimicrobial, cytocompatible, and self-healing hydrogel material. During the design, we showed that caps at the ends of the peptide sequence are important for gelation and placement of His in the sequence (Table 1). On C-term, we have an amide and N-term—acyl, and the presence of charges without caps present a material with 0 Pa and 940 Pa, respectively, thus decreasing gelation of the original peptide FHHF-11 significantly (down from ~50,000 Pa). We demonstrated that the hydrogel has properties needed for wound-healing applications. Here, we show that the RGD-modified hydrogel has improved cell attachment, demonstrating why peptide-based hydrogels have an advantage over polymeric materials. In addition to mentioned peptide advantages, the small size of the peptide and uniform composition of the hydrogel allow the characterization of the material by different experimental and theoretical methods, making peptide-based hydrogels ideal candidates for developing robust structure-activity-morphology relationships. With this advantage of peptides, we are going to study the mechanism of antimicrobial properties using already-developed methods. Peptides have before been used to manufacture pH-responsive hydrogel material, but antimicrobial and self-healing properties important for wound healing applications have not been shown [63]. Histidines have also been used to make self-assembling peptides sensitive to pH [64]. Therefore, using His as a tool to make material pH-responsive is based on solid precedent but also presents innovation in using much simpler peptide-based materials with antimicrobial properties. Here, we provide a review of other pH-sensitive peptide-based materials (Table S1).
In this work, we created a pH-responsive material with suitable properties to create wound dressing. Next, we investigated the contributions of a cation-π interaction to the antibacterial activity of a newly designed peptide hydrogel. Peptides that include tryptophan in the sequence have better antimicrobial properties and better cytocompatibility [43,44,45]. Cation-π interactions are a common feature of many antibacterial peptides, where they assist in the disruption of bacterial membranes. In addition, previous work indicated that having Trp/Arg in the sequence helped with peptide gelation and antimicrobial properties [45]. We found that while incorporation of Trp did not improve the antimicrobial properties of our hydrogel material, Trp-analog, and AzAla did improve these antimicrobial properties.
Our current work is focused on our self-healing hydrogel for cell protection during syringe delivery, as was shown previously for stem cells [65], cortical neurons [66], and fibroblast cells [67,68,69,70]. The material developed in the current work will combine pH-responsiveness and cell protection to deliver fibroblasts when the pH of the wound is low. Therefore, the dressing would adapt to healing stages and deliver cells when they are most needed.

4. Materials and Methods

The Rink Amide resin was purchased from Chem-Impex International, and Fmoc-protected amino acids were purchased from Shanghai GL Biochem Ltd. The reagent N,N-Dimethylformamide (DMF, 99.9%) was purchased from Pharmco by Greenfield Global, and Piperazine was purchased from Chem-Impex International. Milli-Q water from Elix3 Millipore Sigma Water Purification System was used to prepare the samples and buffers.
Peptide synthesis and purification: The peptide was synthesized following the manual Fmoc Solid-Phase Synthesis. Rink Amide resin (ChemImpex, Wood Dale, IL, USA) was swelled at 37 °C shaking at 100 rpm for 1 h, and the coupling of Fmoc-protected amino acids (GL Biochem Shanghai Ltd., Shanghai, China) was also performed at 65 °C. Arginines were double-coupled for 10 min at 65 °C, Lysine residues were coupled for 5 min at 65 °C, and AzAla was coupled for 40 min at room temperature. AzAla amino acid was prepared as previously described [47]. Peptide was acetylated using acetic anhydride mixed with N,N-Diisopropylethylamine, and DMF at the N-terminus at room temperature for 20 min. The peptide was cleaved from the resin, and the side chains were deprotected using the cleavage solution, which is a mixture of trifluoroacetic acid (TFA, 99.9%), H2O, and triisopropylsilane (99.78%) in a ratio of 95:2.5:2.5 by volume for 2 h at room temperature. The crude peptide was precipitated and washed with cold methyl-tert-butyl ether (99.9%). The identity of the peptide was confirmed by the MALDI-TOF mass spectrometry before and after purification (Bruker Microflex MALDI-TOF mass spectrometer (Billerica, MA, USA), Table S2). The peptide was purified using the preparative reverse-phase high-performance liquid chromatography system (Varian ProStar 210 (Palo Alto, CA, USA) preparative reverse-phase high-performance liquid chromatography system with a Jupiter 15 μm C4 300 A, LC column using a linear gradient of solvent A (0.1% TFA in Milli-Q water and solvent B (90% CH3CN, 9.9% Milli-Q water, and 0.1% TFA) with an injection volume of 5 mL and a flow rate of 20 mL/min, room temperature. The purity of the final peptide was evaluated using the analytical high-performance liquid chromatography system (Agilent Infinity II 1260 with an Analytical Zorbax (San Francisco, CA, USA) Eclipse XDB-C18 column (4.6 mm × 150 mm)). Peptide stock solutions were prepared from the lyophilized powder (above 90% purity).
Peptide stock preparation: Pure lyophilized peptides were dissolved in ice-cold MilliQ water to make 12.1 mM stock solutions (2 wt% solution). The concentration of the peptide solution was determined using the UV-Vis spectrophotometer (Agilent (Santa Clara, CA, USA) 8453 UV−Vis spectrophotometer) by measuring the absorbance at 214 nm and ε214= 56,857 M−1 cm−1) [71]. The peptide stock solutions were aliquoted into 150 μL fractions and lyophilized. The lyophilized aliquots were then stored at −20 °C until further use. For AzAla peptide, the concentration of 12.1 mM was determined by measuring the absorbance at 342 nm and ε342= 4212 M−1 cm−1.
Rheology: The storage modulus G′ and loss modulus G″ were monitored for 1 h with a Malvern Kinexus rheometer using a 20 mm diameter parallel plate geometry and a gap height of 0.75 mm. A prepared aliquot of the powdered peptide was dissolved in 150 μL of ice-cold water and vortexed for 10 s to make a solution of 2 wt% peptide. The peptide solution was then centrifuged for 5 min at 6000 rpm to remove bubbles. To prepare gel for measurement of G′evolution, 150 μL of 100 mM Hepes, pH 8.0 was added to the peptide solution. For pH-dependent rheology, 150 μL of a mixture of 100 mM Hepes and 100 mM MOPS (pH 6.0/6.5/7.0/7.5/8.0) was added to the hydrogel solution and pipette mixed. The salt content was not monitored when changing the pH but it is known that salt only positively impacts the gelation properties of peptides containing positive charges in the sequence [72,73,74,75]. Finally, 285 μL of the total solution was pipetted onto the rheometer plate. Gelation was monitored by conducting a continuous oscillatory shear sweep at a constant 0.2% shear strain at a frequency of 6.28 rad/sec (1 Hz) for 1 h at 37 °C. Frequency sweep experiments were conducted at a constant shear strain of 0.2% over a range of frequencies from 0–300 rad/sec. Shear strain sweep experiments were performed at constant 1 Hz frequency over a range of shear strain amplitudes of 0.1–50% strain. The hydrogel samples were assembled by mixing 2 wt% peptide stock in water and buffer (100 mM Hepes, pH 8.0) and incubating at 37 °C for 1 h. The self-healing experiment was done by changing the shear strain from 0.2% to 1000% under a constant frequency of 1 Hz for a period of 30s time, followed by recovery of G′ at 0.2% strain for 1 h.
Cytotoxicity experiment: Cytotoxicity experiments were conducted using live/dead assay. The lyophilized peptide (2 wt%, 75 μL stock) was dissolved in 75 μL of sterile Milli-Q water and placed in 3 wells (25 μL each) of a 96-well plate. The hydrogel was prepared by adding buffer (25 μL of 100 mM HEPES, pH 8.0) to each well containing peptide in water. Hydrogel samples were incubated at 37 °C overnight. The cultured mouse embryonic fibroblast cells (3T3, ATCC) with the medium DMEM (Dulbecco’s Modified Eagle Medium) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (P/S, Gibco) were seeded into the hydrogel samples at a concentration of 1 × 104 cells/well and incubated at 37 °C/5% CO2 for 5 h (pH of the medium was 7.4). The cells with the culture medium were used as the positive control, while the cells treated with 50 μL of 30% H2O2 were used as the negative control. The medium was removed and washed with 1× PBS (200 μL). Then, the samples were treated with 50 μL of 2 μM solution of Live/Dead® assay (live: Calcein AM, green; dead: BOBO-3 Iodide, red, Thermo Fisher Scientific) in each well and incubated for 20 min. During this process, samples were wrapped in aluminum foil prior to the beginning of the fluorescence imaging. The cells were imaged (3 field views/images) on a fluorescence microscope using blue and green light on a Leica DMI 6000B microscope (Wetzlar, Germany).
Antimicrobial studies: The hydrogel samples (70 µL of 1 wt% stock in 50 mM HEPES, pH 8) were prepared by mixing an equal volume of peptide stock in water (2 wt%) and buffer (100 mM Hepes, pH 8). The samples were placed inside 96-well plate (Greiner Bio-one), covered by BreathEasy membrane (Sigma-Aldrich), and incubated at 37 °C without shaking for 6 h. The culture of E. coli (ATCC 25922) and S. aureus (ATCC 25923) were started by diluting glycerol stocks of cells in LB (Luria Bertani, prepared ourselves ) and TSB (Tryptic Soy Broth, Becton, Dickinson, and Company) using 20 µL of E. coli stock in 5 mL of LB (first dilution). Next, the culture was further diluted using 20 µL of E. coli (first dilution) and 5 mL of fresh LB (second dilution), and 30 µL of S. aureus in 5 mL TSB (first dilution). Finally, the culture was further diluted using 30 µL of S. aureus first dilution and 5 mL of fresh TSB (second dilution). After incubation at 37 °C with shaking at 150 rpm for 5 hr, the second dilution of E. coli culture grew to OD600 = 0.8, and the first dilution of S. aureus culture grew to OD600 = 1.1. Both cultures were diluted to OD600 = 0.1 and allowed to grow for 1 h, after which the E. coli culture grew to OD600 = 0.32, and S. aureus grew to OD600 = 0.29. Both cultures were diluted to OD600 = 0.001 separately, and 200 µL of this culture was introduced above each sample, then the plate was covered with a new Breath Easy membrane. After 13 h incubation at 37 °C and 150 rpm, aliquots (100 µL) of each culture in contact with samples were analyzed for OD600 using a plate reader (Thermo Labsystems, Multiscan Spectrum). Control samples with culture were prepared by mixing water and buffer instead of peptide solution and buffer, followed by the culture with OD600 = 0.001 being introduced into the wells. ‘Media’ samples were prepared by mixing water and buffer followed by sterile LB medium or TSB medium addition to each well. Data represent averages of eight wells and two independent preparations of AzAla-containing FHHF-11.
Circular dichroism spectroscopy: The CD spectra were acquired on the Jasco J-715 CD spectrometer by collecting ten scans (4 s averaging time) for each spectrum and using a quartz cuvette with 0.1 mm path length. The measurements were performed on samples containing 0.25 wt% FHHF-11 peptide (3 mM) in buffer pH 6.0 and 8.0 (12.5 mM HEPES, 12.5 mM MOPS). The hydrogel samples were aged at 37 °C overnight to ensure gel formation before measurements. Care was taken that the sample absorbance never exceeded 1.5 at all wavelengths to produce reliable ellipticity values. Mean residue ellipticity (MRE, deg * cm2 * dmol−1) values were calculated using the following equation, where θ is ellipticity (mdeg), l is pathlength (cm), C is peptide concentration (M), N is number of residues.
MRE = θ 10 ∗ C ∗ l ∗ N
Transmission electron microscopy: FHHF-11 hydrogel samples (6 mM, 1%wt/v) in 50 mM HEPES 50 mM MOPS of pH 6 and 8 were prepared and incubated at 37 °C overnight to be aged. After preparation, 3 μL aliquots were applied to carbon-coated 200-mesh copper grids (Ted Pella) and left for 2 min. Excess liquid was wicked away with filter paper, and grids were then stained with one 5 μL drop of 2% (w/v) uranyl acetate, followed by immediate blotting. A second 5 μL drop of 2% (w/v) uranyl acetate was applied and left on the grid for 20 s. This was then blotted away, and grids were stored under a vacuum until imaging. Samples were viewed with a JEOL-JEM 2100F Field Emission electron microscope (Tokyo, Japan) at an acceleration voltage of 200 kV. Electron micrographs were recorded on a Gatan OneView 4K CCD camera (Pleasanton, CA, USA).

Solubilization of Hydrogel

Hydrogel samples (300 μL) containing 1 wt% (6 mM) FHHF-11 in buffer (final 50 mM HEPES, pH 8) were formed in two glass vials and kept overnight at 37 °C. To check the pH-dependent solubility of the hydrogels, 900 µL of buffer (50 mM HEPES, pH 8) was added to one of the vials, and 900 µL of buffer (50 mM MOPS, pH 6) was added to the second vial. Both vials were swirled for 10 min. The vials were inverted to check the solubility of the hydrogels. The hydrogel in the buffer at pH 8 remained stable for about 15 h.

5. Conclusions

In this work, we have successfully created a peptide-based hydrogel that changes its stiffness as a function of pH, being liquid below pH 6 and forming the stiffest hydrogel in the physiological range (pH 7–8). By introducing both antimicrobial and self-healing properties into the hydrogel scaffold, we were able to create cytocompatible, antimicrobial, stimuli-responsive hydrogel materials for wound healing. This work opens the path to new approaches in pH-dependent fibroblast delivery.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28114390/s1. References [63,64,76,77,78,79,80,81,82,83,84,85,86,87,88] are cited in the supplementary materials.

Author Contributions

Conceptualization, O.V.M.; methodology, D.I.U.E., A.E.P., R.J.C., M.R., Q.C., C.L.M., and J.S.; writing—review and editing, O.V.M., D.I.U.E., A.D., R.J.C., A.E.P., M.B.B.M., and M.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by NSF DMR CAREER (2239750) for O.V.M., SU CUSE for M.B.B.M. and O.V.M.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article or Supplementary Material.

Acknowledgments

Authors thank our summer REU student Reagan Brown, who helped to make some of the peptides discussed, and Jennifer Yoon for her help with the synthesis and LCMS analysis of HHF and FHFH peptides.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Sample Availability

Samples of the peptides are available from the authors.

References

  1. Schneider, L.A.; Korber, A.; Grabbe, S.; Dissemond, J. Influence of pH on Wound-healing: A New Perspective for Wound-therapy? Arch. Dermatol. Res. 2007, 298, 413–420. [Google Scholar] [CrossRef]
  2. Petrof, G.; Abdul-Wahab, A.; McGrath, J.A. Cell therapy in dermatology. Cold Spring Harb. Perspect. Med. 2014, 4, a015156. [Google Scholar] [CrossRef]
  3. Huang, G.; Li, F.; Zhao, X.; Ma, Y.; Li, Y.; Lin, M.; Jin, G.; Lu, T.J.; Genin, G.M.; Xu, F. Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment. Chem. Rev. 2017, 117, 12764–12850. [Google Scholar] [CrossRef]
  4. Nicodemus, G.D.; Bryant, S.J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. Part B. Rev. 2008, 14, 149–165. [Google Scholar] [CrossRef] [PubMed]
  5. Wang, H.; Heilshorn, S.C. Adaptable hydrogel networks with reversible linkages for tissue engineering. Adv. Mater. 2015, 27, 3717–3736. [Google Scholar] [CrossRef] [PubMed]
  6. Guvendiren, M.; Lu, H.D.; Burdick, J.A. Shear-thinning hydrogels for biomedical applications. Soft Matter 2012, 8, 260–272. [Google Scholar] [CrossRef]
  7. Yan, C.; Pochan, D.J. Rheological properties of peptide-based hydrogels for biomedical and other applications. Chem. Soc. Rev. 2010, 39, 3528–3540. [Google Scholar] [CrossRef]
  8. Gonzalez-Henriquez, C.M.; Sarabia-Vallejos, M.A.; Rodriguez-Hernandez, J. Advances in the Fabrication of Antimicrobial Hydrogels for Biomedical Applications. Materials 2017, 10, 232. [Google Scholar] [CrossRef]
  9. Veiga, A.S.; Schneider, J.P. Antimicrobial Hydrogels for the Treatment of Infection. Biopolymers 2013, 100, 637–644. [Google Scholar] [CrossRef]
  10. Field, F.K.; Kerstein, M.D. Overview of wound healing in a moist environment. Am. J. Surg. 1994, 167, 2S–6S. [Google Scholar] [CrossRef] [PubMed]
  11. Junker, J.P.; Kamel, R.A.; Caterson, E.J.; Eriksson, E. Clinical Impact Upon Wound Healing and Inflammation in Moist, Wet, and Dry Environments. Adv. Wound Care 2013, 2, 348–356. [Google Scholar] [CrossRef] [PubMed]
  12. Li, J.; Xing, R.; Bai, S.; Yan, X. Recent advances of self-assembling peptide-based hydrogels for biomedical applications. Soft Matter 2019, 15, 1704–1715. [Google Scholar] [CrossRef] [PubMed]
  13. Ahn, W.; Lee, J.-H.; Kim, S.R.; Lee, J.; Lee, E.J. Designed protein- and peptide-based hydrogels for biomedical sciences. J. Mater. Chem. B. 2021, 9, 1919–1940. [Google Scholar] [CrossRef] [PubMed]
  14. Jonker, A.M.; Löwik, D.W.P.M.; van Hest, J.C.M. Peptide- and Protein-Based Hydrogels. Chem. Mater. 2012, 24, 759–773. [Google Scholar] [CrossRef]
  15. Mukherjee, N.; Adak, A.; Ghosh, S. Recent trends in the development of peptide and protein-based hydrogel therapeutics for the healing of CNS injury. Soft Matter 2020, 16, 10046–10064. [Google Scholar] [CrossRef]
  16. Wang, X.J.; Cheng, J.; Zhang, L.Y.; Zhang, J.G. Self-assembling peptides-based nano-cargos for targeted chemotherapy and immunotherapy of tumors: Recent developments, challenges, and future perspectives. Drug. Deliv. 2022, 1, 1184–1200. [Google Scholar] [CrossRef]
  17. Mahmood, A.; Patel, D.; Hickson, B.; DesRochers, J.; Hu, X. Recent Progress in Biopolymer-Based Hydrogel Materials for Biomedical Applications. Int. J. Mol. Sci. 2022, 23, 1415. [Google Scholar] [CrossRef]
  18. Zhang, M.; Zhao, X. Alginate hydrogel dressings for advanced wound management. Int. J. Biol. Macromol. 2020, 162, 1414–1428. [Google Scholar] [CrossRef] [PubMed]
  19. Gray, V.P.; Amelung, C.D.; Duti, I.J.; Laudermilch, E.G.; Letteri, R.A.; Lampe, K.J. Biomaterials via peptide assembly: Design, characterization, and application in tissue engineering. Acta Biomater. 2022, 140, 43–75. [Google Scholar] [CrossRef]
  20. Hersel, U.; Dahmen, C.; Kessler, H. RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24, 4385–4415. [Google Scholar] [CrossRef] [PubMed]
  21. Datta, D.; Chaudhary, N. Chapter 8—Peptide-based hydrogels for biomedical applications. In Translational Biotechnology; Hasija, Y., Ed.; Academic Press: Cambridge, MA, USA, 2021; pp. 203–232. [Google Scholar] [CrossRef]
  22. D’Souza, A.; Marshall, L.R.; Yoon, J.; Kulesha, A.; Edirisinghe, D.I.U.; Chandrasekaran, S.; Rathee, P.; Prabhakar, R.; Makhlynets, O.V. Peptide hydrogel with self-healing and redox-responsive properties. Nano Converg. 2022, 9, 18. [Google Scholar] [CrossRef] [PubMed]
  23. Yang, K.; Han, Q.; Chen, B.; Zheng, Y.; Zhang, K.; Li, Q.; Wang, J. Antimicrobial hydrogels: Promising materials for medical application. Int. J. Nanomed. 2018, 13, 2217–2263. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, Y.S.; Khademhosseini, A. Advances in engineering hydrogels. Science 2017, 356, eaaf3627. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, C.; Zhang, Q.; Zhu, S.; Liu, H.; Chen, J. Preparation and applications of peptide-based injectable hydrogels. RSC Adv. 2019, 9, 28299–28311. [Google Scholar] [CrossRef]
  26. Makhlynets, O.V.; Caputo, G.A. Characteristics and therapeutic applications of antimicrobial peptides. Biophys. Rev. 2021, 2, 011301. [Google Scholar] [CrossRef]
  27. Talebian, S.; Mehrali, M.; Taebnia, N.; Pennisi, C.P.; Kadumudi, F.B.; Foroughi, J.; Hasany, M.; Nikkhah, M.; Akbari, M.; Orive, G.; et al. Self-Healing Hydrogels: The Next Paradigm Shift in Tissue Engineering? Adv. Sci. 2019, 6, 1801664. [Google Scholar] [CrossRef] [PubMed]
  28. Francesko, A.; Petkova, P.; Tzanov, T. Hydrogel Dressings for Advanced Wound Management. Curr. Med. Chem. 2018, 25, 5782–5797. [Google Scholar] [CrossRef]
  29. Saunders, L.; Ma, P.X. Self-Healing Supramolecular Hydrogels for Tissue Engineering Applications. Macromol. Biosci. 2019, 19, e1800313. [Google Scholar] [CrossRef]
  30. Cavanagh, P.R.; Lipsky, B.A.; Bradbury, A.W.; Botek, G. Treatment for diabetic foot ulcers. Lancet 2005, 366, 1725–1735. [Google Scholar] [CrossRef]
  31. Jeffcoate, W.J.; Vileikyte, L.; Boyko, E.J.; Armstrong, D.G.; Boulton, A.J.M. Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers. Diabetes Care 2018, 41, 645–652. [Google Scholar] [CrossRef]
  32. Lindholm, C.; Searle, R. Wound management for the 21st century: Combining effectiveness and efficiency. Int. Wound J. 2016, 13 (Suppl. 2), 5–15. [Google Scholar] [CrossRef] [PubMed]
  33. Cutrona, K.J.; Kaufman, B.A.; Figueroa, D.M.; Elmore, D.E. Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides. FEBS Lett. 2015, 589, 3915–3920. [Google Scholar] [CrossRef]
  34. Kohn, E.M.; Shirley, D.J.; Arotsky, L.; Picciano, A.M.; Ridgway, Z.; Urban, M.W.; Carone, B.R.; Caputo, G.A. Role of Cationic Side Chains in the Antimicrobial Activity of C18G. Molecules 2018, 23, 329. [Google Scholar] [CrossRef]
  35. Yang, C.H.; Chen, Y.C.; Peng, S.Y.; Tsai, A.P.; Lee, T.J.; Yen, J.H.; Liou, J.W. An engineered arginine-rich alpha-helical antimicrobial peptide exhibits broad-spectrum bactericidal activity against pathogenic bacteria and reduces bacterial infections in mice. Sci. Rep. 2018, 8, 14602. [Google Scholar] [CrossRef] [PubMed]
  36. Liu, P.; Zeng, X.; Wen, X. Design and Synthesis of New Cationic Antimicrobial Peptides with Low Cytotoxicity. Int. J. Pept. Res. Ther. 2021, 27, 831–840. [Google Scholar] [CrossRef]
  37. Tomar, D.; Chaudhary, S.; Jena, K.C. Self-assembly of l-phenylalanine amino acid: Electrostatic induced hindrance of fibril formation. RSC Adv. 2019, 9, 12596–12605. [Google Scholar] [CrossRef] [PubMed]
  38. Rajagopal, K.; Lamm, M.S.; Haines-Butterick, L.A.; Pochan, D.J.; Schneider, J.P. Tuning the pH Responsiveness of β-Hairpin Peptide Folding, Self-Assembly, and Hydrogel Material Formation. Biomacromolecules 2009, 10, 2619–2625. [Google Scholar] [CrossRef]
  39. Andersson, D.I.; Hughes, D.; Kubicek-Sutherland, J.Z. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug. Resist. Updat. 2016, 26, 43–57. [Google Scholar] [CrossRef]
  40. Exner, M.; Bhattacharya, S.; Christiansen, B.; Gebel, J.; Goroncy-Bermes, P.; Hartemann, P.; Heeg, P.; Ilschner, C.; Kramer, A.; Larson, E.; et al. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg. Infect. Control. 2017, 12, Doc05. [Google Scholar] [CrossRef]
  41. Blair, J.M.; Webber, M.A.; Baylay, A.J.; Ogbolu, D.O.; Piddock, L.J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13, 42–51. [Google Scholar] [CrossRef]
  42. Epand, R.M.; Walker, C.; Epand, R.F.; Magarvey, N.A. Molecular mechanisms of membrane targeting antibiotics. Biochim. Et. Biophys. Acta -Biomembr. 2016, 1858, 980–987. [Google Scholar] [CrossRef] [PubMed]
  43. Chan, D.I.; Prenner, E.J.; Vogel, H.J. Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action. Biochim. Biophys. Acta 2006, 1758, 1184–1202. [Google Scholar] [CrossRef]
  44. Jing, W.; Demcoe, A.R.; Vogel, H.J. Conformation of a bactericidal domain of puroindoline a: Structure and mechanism of action of a 13-residue antimicrobial peptide. J. Bacteriol. 2003, 185, 4938–4947. [Google Scholar] [CrossRef] [PubMed]
  45. Larsen, T.J.; Salick, D.A.; Nagarkar, R.; Schneider, J. Inherently Antibacterial Hydrogels: Altering Activity via Tryptophan/Arginine Interactions. FASEB J. 2009, 23, 863-14. [Google Scholar] [CrossRef]
  46. Moroz, Y.S.; Binder, W.; Nygren, P.; Caputo, G.A.; Korendovych, I.V. Painting proteins blue: Beta-(1-azulenyl)-L-alanine as a probe for studying protein-protein interactions. Chem. Commun. 2013, 49, 490–492. [Google Scholar] [CrossRef]
  47. D’Souza, A.R.; Necelis, M.R.; Kulesha, A.; Caputo, G.A.; Makhlynets, O.V. Beneficial Impacts of Incorporating the Non-Natural Amino Acid Azulenyl-Alanine into the Trp-Rich Antimicrobial Peptide buCATHL4B. Biomolecules 2021, 11, 421. [Google Scholar] [CrossRef]
  48. Pubell, B. Wound healing and the role of fibroblasts. J. Wound Care 2013, 22, 407–412. [Google Scholar] [CrossRef]
  49. Bellis, S.L. Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials 2011, 32, 4205–4210. [Google Scholar] [CrossRef]
  50. Pierschbacher, M.D.; Ruoslahti, E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309, 30–33. [Google Scholar] [CrossRef]
  51. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol. 1996, 12, 697–715. [Google Scholar] [CrossRef] [PubMed]
  52. Hern, D.L.; Hubbell, J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 1998, 39, 266–276. [Google Scholar] [CrossRef]
  53. Zhou, M.; Ulijn, R.V.; Gough, J.E. Extracellular matrix formation in self-assembled minimalistic bioactive hydrogels based on aromatic peptide amphiphiles. J. Tissue Eng. 2014, 5, 1593. [Google Scholar] [CrossRef] [PubMed]
  54. Zhou, M.; Smith, A.M.; Das, A.K.; Hodson, N.W.; Collins, R.F.; Ulijn, R.V.; Gough, J.E. Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells. Biomaterials 2009, 30, 2523–2530. [Google Scholar] [CrossRef] [PubMed]
  55. Storrie, H.; Guler, M.O.; Abu-Amara, S.N.; Volberg, T.; Rao, M.; Geiger, B.; Stupp, S.I. Supramolecular crafting of cell adhesion. Biomaterials 2007, 28, 4608–4618. [Google Scholar] [CrossRef] [PubMed]
  56. Guler, M.O.; Hsu, L.; Soukasene, S.; Harrington, D.A.; Hulvat, J.F.; Stupp, S.I. Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles. Biomacromolecules 2006, 7, 1855–1863. [Google Scholar] [CrossRef]
  57. Li, Y.; Rodrigues, J.; Tomas, H. Injectable and biodegradable hydrogels: Gelation, biodegradation and biomedical applications. Chem. Soc. Rev. 2012, 41, 2193–2221. [Google Scholar] [CrossRef] [PubMed]
  58. Lee, J.W.; Park, Y.J.; Lee, S.J.; Lee, S.K.; Lee, K.Y. The effect of spacer arm length of an adhesion ligand coupled to an alginate gel on the control of fibroblast phenotype. Biomaterials 2010, 31, 5545–5551. [Google Scholar] [CrossRef] [PubMed]
  59. Menger, F.M.; Caran, K.L. Anatomy of a Gel. Amino Acid Derivatives that Rigidify Water at Submillimolar Concentration. J. Am. Chem. Soc. 2000, 122, 11679–11691. [Google Scholar] [CrossRef]
  60. Lansdown, A.B. Calcium: A potential central regulator in wound healing in the skin. Wound Repair. Regen. 2002, 10, 271–285. [Google Scholar] [CrossRef]
  61. Lange, T.S.; Bielinsky, A.K.; Kirchberg, K.; Bank, I.; Herrmann, K.; Krieg, T.; Scharffetter-Kochanek, K. Mg2+ and Ca2+ differentially regulate beta 1 integrin-mediated adhesion of dermal fibroblasts and keratinocytes to various extracellular matrix proteins. Exp. Cell. Res. 1994, 214, 381–388. [Google Scholar] [CrossRef]
  62. Grzesiak, J.J.; Pierschbacher, M.D. Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J. Clin. Investig. 1995, 95, 227–233. [Google Scholar] [CrossRef]
  63. Lin, B.F.; Megley, K.A.; Viswanathan, N.; Krogstad, D.V.; Drews, L.B.; Kade, M.J.; Qian, Y.; Tirrell, M.V. pH-responsive branched peptide amphiphile hydrogel designed for applications in regenerative medicine with potential as injectable tissue scaffolds. J. Mater. Chem. 2012, 22, 19447–19454. [Google Scholar] [CrossRef]
  64. Hatip Koc, M.; Cinar Ciftci, G.; Baday, S.; Castelletto, V.; Hamley, I.W.; Guler, M.O. Hierarchical Self-Assembly of Histidine-Functionalized Peptide Amphiphiles into Supramolecular Chiral Nanostructures. Langmuir 2017, 33, 7947–7956. [Google Scholar] [CrossRef]
  65. Aguado, B.A.; Mulyasasmita, W.; Su, J.; Lampe, K.J.; Heilshorn, S.C. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 2012, 18, 806–815. [Google Scholar] [CrossRef]
  66. Wang, Y.; He, X.; Bruggeman, K.F.; Gayen, B.; Tricoli, A.; Lee, W.M.; Williams, R.J.; Nisbet, D.R. Peptide programmed hydrogels as safe sanctuary microenvironments for cell transplantation. Adv. Funct. Mater. 2020, 30, 1900390. [Google Scholar] [CrossRef]
  67. Madl, A.C.; Madl, C.M.; Myung, D. Injectable Cucurbit[8]uril-Based Supramolecular Gelatin Hydrogels for Cell Encapsulation. ACS Macro Lett. 2020, 9, 619–626. [Google Scholar] [CrossRef]
  68. Wei, Z.; Yang, J.H.; Liu, Z.; Xu, F.; Zhou, J.X.; Zrínyi, M.; Osada, Y.; Chen, Y.M. Novel Biocompatible Polysaccharide-Based Self-Healing Hydrogel. Adv. Funct. Mater. 2015, 25, 421. [Google Scholar] [CrossRef]
  69. Tang, J.D.; Roloson, E.B.; Amelung, C.D.; Lampe, K.J. Rapidly Assembling Pentapeptides for Injectable Delivery (RAPID) Hydrogels as Cytoprotective Cell Carriers. ACS Biomater. Sci. Eng. 2019, 5, 2117–2121. [Google Scholar] [CrossRef] [PubMed]
  70. Amer, M.H.; Felicity, R.A.J.R.; Shakesheff, K.M.; Modo, M.; White, L.J. Translational considerations in injectable cell-based therapeutics for neurological applications: Concepts, progress and challenges. NPJ Regen. Med. 2017, 2, 1–13. [Google Scholar] [CrossRef] [PubMed]
  71. Kuipers, B.J.H.; Gruppen, H. Prediction of Molar Extinction Coefficients of Proteins and Peptides Using UV Absorption of the Constituent Amino Acids at 214 nm To Enable Quantitative Reverse Phase High-Performance Liquid Chromatography−Mass Spectrometry Analysis. J. Agric. Food Chem. 2007, 55, 5445–5451. [Google Scholar] [CrossRef]
  72. Bowerman, C.J.; Liyanage, W.; Federation, A.J.; Nilsson, B.L. Tuning Beta-sheet Peptide Self-assembly and Hydrogelation Behavior by Modification of Sequence Hydrophobicity and Aromaticity. Biomacromolecules 2011, 12, 2735–2745. [Google Scholar] [CrossRef] [PubMed]
  73. Ozbas, B.; Kretsinger, J.; Rajagopal, K.; Schneider, J.P.; Pochan, D.J. Salt-triggered Peptide Folding and Consequent Self-assembbly into Hydrogels with Tunable Modulus. Macromolecules 2004, 37, 7331–7337. [Google Scholar] [CrossRef]
  74. Caplan, M.R.; Schwartzfarb, E.M.; Zhang, S.; Kamm, R.D.; Lauffenburger, D.A. Control of Self-assembling Oligopeptide Matrix Formation Through Systematic Variation of Amino Acid Sequence. Biomaterials 2002, 23, 219–227. [Google Scholar] [CrossRef]
  75. D’Souza, A.; Yoon, J.H.; Beaman, H.; Gosavi, P.; Lengyel-Zhand, Z.; Sternisha, A.; Centola, G.; Marshall, L.R.; Wehrman, M.D.; Schultz, K.M.; et al. Nine-Residue Peptide Self-Assembles in the Presence of Silver to Produce a Self-Healing, Cytocompatible, Antimicrobial Hydrogel. ACS Appl. Mater. Interfaces 2020, 12, 17091–17099. [Google Scholar] [CrossRef] [PubMed]
  76. Zhu, Y.; Wang, L.; Li, Y.; Huang, Z.; Luo, S.; He, Y.; Han, H.; Raza, F.; Wu, J.; Ge, L. Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug delivery. Biomater Sci 2020, 8, 5415–5426. [Google Scholar] [CrossRef]
  77. Ghosh, G.; Barman, R.; Sarkar, J.; Ghosh, S. pH-Responsive Biocompatible Supramolecular Peptide Hydrogel. J. Phys. Chem. B 2019, 123, 5909–5915. [Google Scholar] [CrossRef]
  78. Raza, F.; Zhu, Y.; Chen, L.; You, X.; Zhang, J.; Khan, A.; Khan, M.W.; Hasnat, M.; Zafar, H.; Wu, J.; et al. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting. Biomater. Sci. 2019, 7, 2023–2036. [Google Scholar] [CrossRef]
  79. Kaur, H.; Sharma, P.; Patel, N.; Pal, V.K.; Roy, S. Accessing Highly Tunable Nanostructured Hydrogels in a Short Ionic Complementary Peptide Sequence via pH Trigger. Langmuir 2020, 36, 12107–12120. [Google Scholar] [CrossRef]
  80. Liu, Y.; Ran, Y.; Ge, Y.; Raza, F.; Li, S.; Zafar, H.; Wu, Y.; Paiva-Santos, A.C.; Yu, C.; Sun, M.; et al. pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment. Pharmaceutics 2022, 14. [Google Scholar] [CrossRef] [PubMed]
  81. Yamamoto, S.; Nishimura, K.; Morita, K.; Kanemitsu, S.; Nishida, Y.; Morimoto, T.; Aoi, T.; Tamura, A.; Maruyama, T. Microenvironment pH-Induced Selective Cell Death for Potential Cancer Therapy Using Nanofibrous Self-Assembly of a Peptide Amphiphile. Biomacromolecules 2021, 22, 2524–2531. [Google Scholar] [CrossRef]
  82. Schneider, J.P.; Pochan, D.J.; Ozbas, B.; Rajagopal, K.; Pakstis, L.; Kretsinger, J. Responsive Hydrogels from the Intramolecular Folding and Self-Assembly of a Designed Peptide. J. Am. Chem. Soc. 2002, 124, 15030–15037. [Google Scholar] [CrossRef] [PubMed]
  83. Dexter, A.F.; Fletcher, N.L.; Creasey, R.G.; Filardo, F.; Boehm, M.W.; Jack, K.S. Fabrication and characterization of hydrogels formed from designer coiled-coil fibril-forming peptides. RSC Advances 2017, 7, 27260–27271. [Google Scholar] [CrossRef]
  84. Liu, Y.; Yang, Y.; Wang, C.; Zhao, X. Stimuli-responsive self-assembling peptides made from antibacterial peptides. Nanoscale 2013, 5, 6413–6421. [Google Scholar]
  85. Bortolini, C.; Liu, L.; Hoffmann, S.V.; Jones, N.C.; Knowles, T.P.J.; Dong, M. Exciton Coupling of Phenylalanine Reveals Conformational Changes of Cationic Peptides. ChemistrySelect 2017, 2, 2476–2479. [Google Scholar] [CrossRef]
  86. Decandio, C.C.; Silva, E.R.; Hamley, I.W.; Castelletto, V.; Liberato, M.S.; Oliveira, V.X.; Oliveira, C.L.P.; Alves, W.A. Self-Assembly of a Designed Alternating Arginine/Phenylalanine Oligopeptide. Langmuir 2015, 31, 4513–4523. [Google Scholar] [CrossRef]
  87. Perween, S.; Chandanshive, B.; Kotamarthi, H.C.; Khushalani, D. Single amino acid based self-assembled structure. Soft Matter 2013, 9, 10141–10145. [Google Scholar] [CrossRef]
  88. Krysmann, M.J.; Castelletto, V.; Kelarakis, A.; Hamley, I.W.; Hule, R.A.; Pochan, D.J. Self-Assembly and Hydrogelation of an Amyloid Peptide Fragment. Biochemistry 2008, 47, 4597–4605. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 04390 g001 550
Figure 1. Sequence of pH sensitive peptide, namely, FHHF-11, and pH sensitivity of the peptide. The picture on the right was taken after the FHHF-11 peptide (1 wt%) was incubated with the buffer (100 mM HEPES, 100 mM MOPS, pH 6 or pH 8) for 15 min at 37 °C.
Figure 1. Sequence of pH sensitive peptide, namely, FHHF-11, and pH sensitivity of the peptide. The picture on the right was taken after the FHHF-11 peptide (1 wt%) was incubated with the buffer (100 mM HEPES, 100 mM MOPS, pH 6 or pH 8) for 15 min at 37 °C.
Molecules 28 04390 g001
Molecules 28 04390 g002 550
Figure 2. Incorporation of AzAla non-natural amino acid (A) improves the antimicrobial properties of the FHHF-11 peptide (B,C). FHHF-AzAla is FHHF-11 with AzAla amino acid. Experiments represent the average of eight wells and two independent preparations of AzAla peptides (synthesis and stock preparation).
Figure 2. Incorporation of AzAla non-natural amino acid (A) improves the antimicrobial properties of the FHHF-11 peptide (B,C). FHHF-AzAla is FHHF-11 with AzAla amino acid. Experiments represent the average of eight wells and two independent preparations of AzAla peptides (synthesis and stock preparation).
Molecules 28 04390 g002
Molecules 28 04390 g003 550
Figure 3. Live/dead assay for the mouse embryonic fibroblast cells: control with live (A) and dead cells (B) and fibroblasts on the surface of FHHF-11 hydrogel showing live (C) and dead (D) cells. The morphology of the gel is uneven and has a multiple number of planes. Incubation time of cells on hydrogel is 5 h at 37 °C. DMEM + FSB medium (pH 7.4) was used for the incubation.
Figure 3. Live/dead assay for the mouse embryonic fibroblast cells: control with live (A) and dead cells (B) and fibroblasts on the surface of FHHF-11 hydrogel showing live (C) and dead (D) cells. The morphology of the gel is uneven and has a multiple number of planes. Incubation time of cells on hydrogel is 5 h at 37 °C. DMEM + FSB medium (pH 7.4) was used for the incubation.
Molecules 28 04390 g003
Molecules 28 04390 g004 550
Figure 4. Rheology data for FHHF-11 hydrogel (1 wt%). (A) Evolution of storage modulus over time, where the red curve represents storage modulus (G′), and the black curve shows loss modulus (G″), pH 8.0. (B) The storage modulus (G′) evolution as a function of hydrogel pH. (C) The storage modulus during a self-healing test where the shear strain amplitude is increased from 0.2% strain to 1000% strain to examine the self-healing properties at 37 °C, 100 mM HEPES, pH 8, 285 μL).
Figure 4. Rheology data for FHHF-11 hydrogel (1 wt%). (A) Evolution of storage modulus over time, where the red curve represents storage modulus (G′), and the black curve shows loss modulus (G″), pH 8.0. (B) The storage modulus (G′) evolution as a function of hydrogel pH. (C) The storage modulus during a self-healing test where the shear strain amplitude is increased from 0.2% strain to 1000% strain to examine the self-healing properties at 37 °C, 100 mM HEPES, pH 8, 285 μL).
Molecules 28 04390 g004
Molecules 28 04390 g005 550
Figure 5. Dissolution of the hydrogel in buffer pH 6 takes only 10 min. The vial on the left is hydrogel in buffer pH 8 (remains stable hydrogel for hours), and on the right is shown the same hydrogel but in pH 6 buffer.
Figure 5. Dissolution of the hydrogel in buffer pH 6 takes only 10 min. The vial on the left is hydrogel in buffer pH 8 (remains stable hydrogel for hours), and on the right is shown the same hydrogel but in pH 6 buffer.
Molecules 28 04390 g005
Table
Table 1. Rheological properties of hydrogels (1 wt% of peptides) measured at 0.2% strain, 37 °C after 1 hr. All runs were done in triplicates using 50 mM HEPES and 50 mM MOPS in the pH range 6–8, and the error bars represent standard deviation. Experiments at pH 8 were done in the following buffer concertation: 50 mM Hepes, pH 8 (final concentration).
Table 1. Rheological properties of hydrogels (1 wt% of peptides) measured at 0.2% strain, 37 °C after 1 hr. All runs were done in triplicates using 50 mM HEPES and 50 mM MOPS in the pH range 6–8, and the error bars represent standard deviation. Experiments at pH 8 were done in the following buffer concertation: 50 mM Hepes, pH 8 (final concentration).
Peptide NamepHPeptide SequenceShear Modulus G′ (Pa)
FHHF-118Ac-FHHFRFRFHHF-CONH251,466 ± 4800
7.542,000 ± 6850
740,100 ± 2250
6.535,350 ± 4950
60.7 ± 0.2
FHHF-K8Ac-FHHFKFKFHHF-CONH294,000 ± 9000
7.589,200 ± 28,800
767,050 ± 10,550
6.525,350 ± 10,750
60.3 ± 0.1
No-Ac FHHF-118NH2-FHHFRFRFHHF-CONH2940 ± 340
COOH FHHF-118Ac-FHHFRFRFHHF-COOH0
HHF8Ac-HHFRFRFRFHH-CONH230
HFH8Ac-HFHFRFRFHFH-CONH265
FHFH8Ac-FHFHFRFRFHFHF-CONH260
FHHF-GRGD8Ac-FHHFRFRFHHFGRGD-CONH22620 ±360
W substitutions8Ac-WHHFRFRFHHF-CONH2865 ± 126
8Ac-FHHFRFRFHHW-CONH2125 ± 75
8Ac-FHWFRFRFHHF-CONH219 ± 9
8Ac-FHHFRWRFHHF-CONH25361 ± 3448
8Ac-FHHFKWKFHHF-CONH24140 ± 2356
8Ac-FHHFRFWFHHF-CONH2435 ± 339
8Ac-FHHFWFRFHHF-CONH2205 ± 168
AzAla substitutions8Ac-FHHFR(AzAla)RFHHF-CONH210,520 ± 3790
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Edirisinghe, D.I.U.; D’Souza, A.; Ramezani, M.; Carroll, R.J.; Chicón, Q.; Muenzel, C.L.; Soule, J.; Monroe, M.B.B.; Patteson, A.E.; Makhlynets, O.V. Antibacterial and Cytocompatible pH-Responsive Peptide Hydrogel. Molecules 2023, 28, 4390. https://doi.org/10.3390/molecules28114390

AMA Style

Edirisinghe DIU, D’Souza A, Ramezani M, Carroll RJ, Chicón Q, Muenzel CL, Soule J, Monroe MBB, Patteson AE, Makhlynets OV. Antibacterial and Cytocompatible pH-Responsive Peptide Hydrogel. Molecules. 2023; 28(11):4390. https://doi.org/10.3390/molecules28114390

Chicago/Turabian Style

Edirisinghe, Dona Imanga Upamadi, Areetha D’Souza, Maryam Ramezani, Robert J. Carroll, Quenten Chicón, Cheyene L. Muenzel, Jonathan Soule, Mary Beth Browning Monroe, Alison E. Patteson, and Olga V. Makhlynets. 2023. "Antibacterial and Cytocompatible pH-Responsive Peptide Hydrogel" Molecules 28, no. 11: 4390. https://doi.org/10.3390/molecules28114390

Article Metrics

Back to TopTop